Trial Profile
Treatment protocol for elderly patients with mantle cell lymphoma (MCL). A phase II study of the Finnish Lymphoma Group.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 17 Jan 2015
Price :
$35
*
At a glance
- Drugs Rituximab (Primary)
- Indications Mantle-cell lymphoma
- Focus Therapeutic Use
- 17 Jan 2015 New trial record